Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Q3 Report Notes Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Revenue Growth of 93 percent YOY

Red White & Bloom Brands is a cannabis multi-state operator building on opportunities in Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts to create a synergistic portfolio throughout North America RWB is also building its hemp-based CBD products retail throughout the United States and into international markets The company has released its third quarter financial […]

Nowigence Inc. (NOWG) Proprietary Platform — Pluaris — Poised for Growth in AI-Focused New Year

Global crisis accelerated adoption of analytics and AI; momentum will continue into the 2020s. An estimated 86% of survey respondents say that AI is becoming a “mainstream technology.” Pluaris generates an annotated data feed based on specified topics of interest. Accelerated by the global pandemic, the adoption of artificial intelligence (“AI”) is gaining steam, with […]

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Announces Completion of Target-Based Model in Its AI-Driven Drug Discovery Program

The AI-driven drug discovery program uses not only artificial intelligence but also machine learning, which is a relatively new concept and is continuously expanding The use of artificial intelligence in the drug development space may help eliminate or reduce the manual operations that a company typically must undergo to identify and make necessary improvements to […]

Congressman Calls for Liberalized Access to Psilocybin; Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Positions for Growth Within Psychedelics Sector

Congressman Earl Blumenauer recently wrote to his peers, urging them to petition the DEA to permit terminally ill patients to use psilocybin as part of their treatment Although 41 states permit terminal patients to try investigational drugs, psilocybin continues to be banned by the DEA Change seems to be coming within the sector as evidenced […]

As Bitcoin Marks 13th Anniversary, LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Works Toward Widespread Cryptocurrency Adoption via Lightning Network PaaS Offering

Bitcoin saw many different milestones during 2021, including surpassing $1 trillion in market value LQwD launched its PaaS, lqwd.tech, on November 17, amidst the Adopting Bitcoin – A Lightning Summit in El Salvador The Lightning Network has seen explosive growth since January 2021 LQwD’s corporate and operational update highlights several of the company’s achievements regarding […]

BlockFi Poised to Build on Momentum Following Blockbuster 2021

Bitcoin prices rose to an all-time high of $69K in 2021, spurring a tide of consumer interest in the cryptocurrency market BlockFi capitalized on this demand through the release of the first-ever crypto rewards credit card, signing up 75,000 clients in 2021 Improvements to its trading experience helped BlockFi expand its overall client base from […]

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Welcomes Addition to Leadership Team Amid Mining Option Advances for 2022

StraightUp has hired experienced commodities entrepreneur and economic geologist Rod Husband as its new CEO as it enters 2022 in an expansionist phase Mineral property exploration company StraightUp Resources is building excitement for several properties it has optioned in the gold-producing region of Ontario’s famed Red Lake Mining District StraightUp also acquired a mine in […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Participation in Upcoming Events Recognizes Company Expertise

CEO to participate in panel discussion, fireside chat focusing on psychedelics The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape CYBN is implementing a three-pillar strategy Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should “de-risk” outcomes prior to Lexaria’s planned entry into regulatory pathways for the […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.